Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT).

@article{stergaard2013PersistenceOA,
  title={Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT).},
  author={Lars J\orgen \Ostergaard and Marie van der Wielen and V{\'e}ronique Bianco and Jacqueline Miller},
  journal={International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  year={2013},
  volume={17 3},
  pages={e173-6}
}
OBJECTIVES A primary dose of the European Union (EU)-licensed meningococcal A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT) was immunogenic and well-tolerated in subjects aged 15-19 years. This study assessed antibody persistence at 3.5 years after vaccination with a MenACWY-TT or a tetravalent ACWY polysaccharide vaccine (MenPS, control… CONTINUE READING